About Index Trending news
Lists
Pricing
PolyPid

PolyPid

PolyPid

PolyPid is a clinical stage emerging specialty pharmaceutical company, engaged in research and development of products based on PLEX (PolymerLipid Encapsulation MatriX), a proprietary drug delivery technology.

Elsewhere

Alexa global traffic share

Latest funding Show all
Venture capital (Series UNDISCLOSED)
$5,300,000
Venture capital (Series D)
$22,000,000
Aurum Ventures, Shavit Capital, Chaim Hurvitz
Employees

Team size

10+
Locations
HQ
Headquarters
$22,000,000 Venture capital (Series D)
FinSMEs , NoCamels

PolyPid Closes $22M Equity Financing

Health Funding